Furthermore, treatments that drop Aβ levels, including β2-adrenergic agonist [46] or a drug that blocks amyloidogenic APP cleavage [47], are effective in restoring neurogenesis in AD mice. This evidence concerns the gene APP and Alzheimer disease.